Juvederm Volbella XC is an amazing new filler in the Allergan family of products that is transforming the way we treat fine lines around the lips and mouth. With gentle, natural and awesomely long-lasting results, Volbella is FDA-approved for treating perioral rhytids and has quickly become the injectable of choice for those who want to softly and subtly enhance the overall shape of their lips.
What Are Perioral Rhytids?
Perioral rhytids, often referred to as perioral lines, are wrinkles around the edges of the lips. They usually consist of fine horizontal lines and deeper wrinkles framing the lips, and are typically found after the age of 40.
A major sign of aging, these lines are sometimes referred to as “smoker’s lines” because they are very common in those who smoke or have smoked, the process of puckering the lips around a cigarette being the catalyst. However, perioral rhytids can also take place in those who have never smoked at all. Some individuals develop these “smoker lines” simply as a result of their genetics or from frequent sun damage
How Can Volbella Help?
Juvederm Volbella XC has been specifically designed to alleviate perioral lines in a way unlike any other filler. It works by gently increasing the volume of the lips, which works to smooth out fine lines and wrinkles without creating an over-enhanced pout.
Loss of volume in the lips is a very common effect of aging along with perioral lines, so Volbella is an excellent choice for those who feel they have lost the natural shape of their lips as a result lines and volume loss. By carefully injecting Volbella into multiple areas of the lips, it is possible to restore the natural shape of the lips, minimize the appearance of lines and create a more youthful looking pout.
Since Volbella has such a soft consistency, it could also be used to gently smooth out crows feet, add a touch of extra volume to nasolabial folds (the lines which run from the outside of the nose to the outside of the mouth), and even smooth out other fine wrinkles elsewhere on the face.